Economic Benefits of Switching From Intravenous to Subcutaneous Epoetin Alfa for the Management of Anemia in Hemodialysis Patients.

Bhanu Prasad Maryam JafariJulie ToppingsLinda GrossJoanne KappelFlora Au

Published in: Canadian journal of kidney health and disease (2020)

The study was not registered on a publicly accessible registry as it was a retrospective chart review and exempted from review by the Research Ethics Board of the former Regina Qu'Appelle Health Region.

Keyphrases

public health
healthcare
mental health
high dose
replacement therapy
global health
social media